SymBio Pharmaceuticals (TYO: 4582)

Last close As at 20/05/2024

717.00

0.00 (0.00%)

Market capitalisation

27,591m

Edison Investment Research is terminating coverage on SymBio Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

SymBio Pharmaceuticals — Treakisym approved for DLBCL

Healthcare | Update

SymBio Pharmaceuticals — Now with commercial operations

Healthcare | Update

SymBio Pharmaceuticals — Treakisym RTD approved

Share Price Performance

Financials

Edison Investment Research is terminating coverage on SymBio Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free